Search research articles
Contact Us
Filters
Showing results (51-60 of 77) with videos related to
Page
of 8
Sort By:
Casopis Lekaru Ceskych
|
January 15, 2021
DNA repair in head and neck tumor cells and possibilities of its monitoring to estimate individual tumor radioresistance and selection of optimal primary treatment
Zuzana Horáková, Jaromír Gumulec, Olga Kopečná, et al.
Langmuir : the ACS Journal of Surfaces and Colloids
|
October 20, 2018
Changes in Cryopreserved Cell Nuclei Serve as Indicators of Processes during Freezing and Thawing
Irena Kratochvílová, Olga Kopečná, Alena Bačíková, et al.
Nanoscale
|
February 4, 2026
Nanoscale topology of γH2AX and 53BP1 foci in U87 cancer cells and normal NHDF after high-LET radiation-induced DSB repair
Kim Annabel Küntzelmann, Laura Rozo Pardo, Myriam Schäfer, et al.
International Journal of Molecular Sciences
|
August 13, 2020
In Vitro Comparison of Passive and Active Clinical Proton Beams
Anna Michaelidesová, Jana Vachelová, Jana Klementová, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
February 19, 2013
Function of chromatin structure and dynamics in DNA damage, repair and misrepair: γ-rays and protons in action
Lucie Ježková, Martin Falk, Iva Falková, et al.
International Journal of Molecular Sciences
|
February 11, 2023
Spatial-Temporal Genome Regulation in Stress-Response and Cell-Fate Change
Jekaterina Erenpreisa, Alessandro Giuliani, Kenichi Yoshikawa, et al.
Nature
|
June 7, 2019
Heterochromatin drives compartmentalization of inverted and conventional nuclei
Martin Falk, Yana Feodorova, Natalia Naumova, et al.
British Journal of Cancer
|
May 27, 2021
Phase 1 study of the ATR inhibitor berzosertib (formerly M6620, VX-970) combined with gemcitabine ± cisplatin in patients with advanced solid tumours
Mark R Middleton, Emma Dean, Thomas R J Evans, et al.
British Journal of Cancer
|
May 27, 2021
Phase 1 study of the ATR inhibitor berzosertib in combination with cisplatin in patients with advanced solid tumours
Geoffrey I Shapiro, Robert Wesolowski, Craig Devoe, et al.
Nature
|
August 4, 2019
Publisher Correction: Heterochromatin drives compartmentalization of inverted and conventional nuclei
Martin Falk, Yana Feodorova, Natalia Naumova, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 77) with videos related to
Sort By:
Page
of 8
Casopis Lekaru Ceskych
|
January 15, 2021
DNA repair in head and neck tumor cells and possibilities of its monitoring to estimate individual tumor radioresistance and selection of optimal primary treatment
Zuzana Horáková, Jaromír Gumulec, Olga Kopečná, et al.
Langmuir : the ACS Journal of Surfaces and Colloids
|
October 20, 2018
Changes in Cryopreserved Cell Nuclei Serve as Indicators of Processes during Freezing and Thawing
Irena Kratochvílová, Olga Kopečná, Alena Bačíková, et al.
Nanoscale
|
February 4, 2026
Nanoscale topology of γH2AX and 53BP1 foci in U87 cancer cells and normal NHDF after high-LET radiation-induced DSB repair
Kim Annabel Küntzelmann, Laura Rozo Pardo, Myriam Schäfer, et al.
International Journal of Molecular Sciences
|
August 13, 2020
In Vitro Comparison of Passive and Active Clinical Proton Beams
Anna Michaelidesová, Jana Vachelová, Jana Klementová, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
February 19, 2013
Function of chromatin structure and dynamics in DNA damage, repair and misrepair: γ-rays and protons in action
Lucie Ježková, Martin Falk, Iva Falková, et al.
International Journal of Molecular Sciences
|
February 11, 2023
Spatial-Temporal Genome Regulation in Stress-Response and Cell-Fate Change
Jekaterina Erenpreisa, Alessandro Giuliani, Kenichi Yoshikawa, et al.
Nature
|
June 7, 2019
Heterochromatin drives compartmentalization of inverted and conventional nuclei
Martin Falk, Yana Feodorova, Natalia Naumova, et al.
British Journal of Cancer
|
May 27, 2021
Phase 1 study of the ATR inhibitor berzosertib (formerly M6620, VX-970) combined with gemcitabine ± cisplatin in patients with advanced solid tumours
Mark R Middleton, Emma Dean, Thomas R J Evans, et al.
British Journal of Cancer
|
May 27, 2021
Phase 1 study of the ATR inhibitor berzosertib in combination with cisplatin in patients with advanced solid tumours
Geoffrey I Shapiro, Robert Wesolowski, Craig Devoe, et al.
Nature
|
August 4, 2019
Publisher Correction: Heterochromatin drives compartmentalization of inverted and conventional nuclei
Martin Falk, Yana Feodorova, Natalia Naumova, et al.
Page
of 8